|
1
|
Dong J, Liu Y, Liao W, Liu R, Shi P and
Wang L: miRNA-223 is a potential diagnostic and prognostic marker
for osteosarcoma. J Bone Oncol. 5:74–79. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang M, Xie R, Si H and Shen B: Integrated
bioinformatics analysis of miRNA expression in osteosarcoma. Artif
Cells Nanomed Biotechnol. Jun 17–2016.Epub ahead of print.
View Article : Google Scholar
|
|
3
|
Di Fiore R, Drago-Ferrante R, Pentimalli
F, Di Marzo D, Forte IM, Carlisi D, De Blasio A, Tesoriere G,
Giordano A and Vento R: Let-7d miRNA shows both antioncogenic and
oncogenic functions in osteosarcoma-derived 3AB-OS cancer stem
cells. J Cell Physiol. 231:1832–1841. 2016. View Article : Google Scholar
|
|
4
|
Guo B, Hui Q, Zhang Y, Chang P and Tao K:
miR-194 is a negative regulator of GEF-H1 pathway in melanoma.
Oncol Rep. 36:2412–2420. 2016.PubMed/NCBI
|
|
5
|
Zhang W, Han S and Sun K: Combined
analysis of gene expression, miRNA expression and DNA methylation
profiles of osteosarcoma. Oncol Rep. 37:1175–1181. 2017.
|
|
6
|
Zhang H, Guo X, Feng X, Wang T, Hu Z, Que
X, Tian Q, Zhu T, Guo G, Huang W, et al: MiRNA-543 promotes
osteosarcoma cell proliferation and glycolysis by partially
suppressing PRMT9 and stabilizing HIF-1α protein. Oncotarget.
8:2342–2355. 2017.
|
|
7
|
Montanini L, Lasagna L, Barili V, Jonstrup
SP, Murgia A, Pazzaglia L, Conti A, Novello C, Kjems J, Perris R,
et al: MicroRNA cloning and sequencing in osteosarcoma cell lines:
Differential role of miR-93. Cell Oncol (Dordr). 35:29–41. 2012.
View Article : Google Scholar
|
|
8
|
Liu H, Wang H, Liu H and Chen Y: Effect of
miR-143 on the apoptosis of osteosarcoma cells. Int J Clin Exp
Pathol. 8:14241–14246. 2015.
|
|
9
|
Hirahata M, Osaki M, Kanda Y, Sugimoto Y,
Yoshioka Y, Kosaka N, Takeshita F, Fujiwara T, Kawai A, Ito H, et
al: PAI-1, a target gene of miR-143, regulates invasion and
metastasis by upregulating MMP-13 expression of human osteosarcoma.
Cancer Med. 5:892–902. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li F, Li S and Cheng T: TGF-beta1 promotes
osteosarcoma cell migration and invasion through the
miR-143-versican pathway. Cell Physiol Biochem. 34:2169–2179. 2014.
View Article : Google Scholar
|
|
11
|
Wang Q, Cai J, Wang J, Xiong C and Zhao J:
miR-143 inhibits EGFR-signaling-dependent osteosarcoma invasion.
Tumour Biol. 35:12743–12748. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ziyan W and Yang L: MicroRNA-21 regulates
the sensitivity to cisplatin in a human osteosarcoma cell line. Ir
J Med Sci. 185:85–91. 2016. View Article : Google Scholar
|
|
13
|
Yuan J, Chen L, Chen X, Sun W and Zhou X:
Identification of serum microRNA-21 as a biomarker for
chemosensitivity and prognosis in human osteosarcoma. J Int Med
Res. 40:2090–2097. 2012. View Article : Google Scholar
|
|
14
|
Ziyan W, Shuhua Y, Xiufang W and Xiaoyun
L: MicroRNA-21 is involved in osteosarcoma cell invasion and
migration. Med Oncol. 28:1469–1474. 2011. View Article : Google Scholar
|
|
15
|
Halldorsson A, Brooks S, Montgomery S and
graham S: Lung metastasis 21 years after initial diagnosis of
osteosarcoma: A case report. J Med Case Rep. 3:92982009. View Article : Google Scholar
|
|
16
|
Min L, Hong S, Duan H, Zhou Y, Zhang W,
Luo Y, Shi R and Tu C: Antidifferentiation noncoding RNA regulates
the proliferation of osteosarcoma cells. Cancer Biother Radiopharm.
31:52–57. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu X, Min L, Duan H, Shi R, Zhang W, Hong
S and Tu C: Short hairpin RNA (shRNA) of type 2 interleukin-1
receptor (IL1R2) inhibits the proliferation of human osteosarcoma
U-2 OS cells. Med Oncol. 32:3642015. View Article : Google Scholar
|
|
18
|
Fan L, Wu Q, Xing X, Wei Y and Shao Z:
MicroRNA-145 targets vascular endothelial growth factor and
inhibits invasion and metastasis of osteosarcoma cells. Acta
Biochim Biophys Sin (Shanghai). 44:407–414. 2012. View Article : Google Scholar
|
|
19
|
Segaliny AI, Mohamadi A, Dizier B,
Lokajczyk A, Brion R, Lanel R, Amiaud J, Charrier C, Boisson-Vidal
C and Heymann D: Interleukin-34 promotes tumor progression and
metastatic process in osteosarcoma through induction of
angiogenesis and macrophage recruitment. Int J Cancer. 137:73–85.
2015. View Article : Google Scholar
|
|
20
|
Watanabe A, Yoneyama S, Nakajima M, Sato
N, Takao-Kawabata R, Isogai Y, Sakurai-Tanikawa A, Higuchi K,
Shimoi A, Yamatoya H, et al: Osteosarcoma in Sprague-Dawley rats
after long-term treatment with teriparatide (human parathyroid
hormone (1–34)). J Toxicol Sci. 37:617–629. 2012. View Article : Google Scholar
|
|
21
|
He C, Xiong J, Xu X, Lu W, Liu L, Xiao D
and Wang D: Functional elucidation of miR-34 in osteosarcoma cells
and primary tumor samples. Biochem Biophys Res Commun. 388:35–40.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang G, Nishimoto K, Zhou Z, Hughes D and
Kleinerman ES: miR-20a encoded by the miR-17-92 cluster increases
the metastatic potential of osteosarcoma cells by regulating Fas
expression. Cancer Res. 72:908–916. 2012. View Article : Google Scholar :
|
|
23
|
Liu LH, Li H, Li JP, Zhong H, Zhang HC,
Chen J and Xiao T: miR-125b suppresses the proliferation and
migration of osteosarcoma cells through down-regulation of STAT3.
Biochem Biophys Res Commun. 416:31–38. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Song B, Wang Y, Titmus MA, Botchkina G,
Formentini A, Kornmann M and Ju J: Molecular mechanism of
chemoresistance by miR-215 in osteosarcoma and colon cancer cells.
Mol Cancer. 9:962010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shi XF, Wang H, Kong FX, Xu QQ, Xiao FJ,
Yang YF, Ge RL and Wang LS: Exosomal miR-486 regulates
hypoxia-induced erythroid differentiation of erythroleukemia cells
through targeting Sirt1. Exp Cell Res. 351:74–81. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
27
|
Zhang X, Zhang T, Yang K, Zhang M and Wang
K: miR-486-5p suppresses prostate cancer metastasis by targeting
Snail and regulating epithelial-mesenchymal transition. Onco
Targets Ther. 9:6909–6914. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ye H, Yu X, Xia J, Tang X, Tang L and Chen
F: miR-486-3p targeting ECM1 represses cell proliferation and
metastasis in cervical cancer. Biomed Pharmacother. 80:109–114.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shao Y, Shen YQ, Li YL, Liang C, Zhang BJ,
Lu SD, He YY, Wang P, Sun QL, Jin YX, et al: Direct repression of
the oncogene CDK4 by the tumor suppressor miR-486-5p in non-small
cell lung cancer. Oncotarget. 7:34011–34021. 2016.PubMed/NCBI
|
|
30
|
Wang J, Tian X, Han R, Zhang X, Wang X,
Shen H, Xue L, Liu Y, Yan X, Shen J, et al: Downregulation of
miR-486-5p contributes to tumor progression and metastasis by
targeting protumorigenic ARHGAP5 in lung cancer. Oncogene.
33:1181–1189. 2014. View Article : Google Scholar :
|
|
31
|
Tahiri A, Leivonen SK, Lüders T, Steinfeld
I, Ragle Aure M, Geisler J, Mäkelä R, Nord S, Riis ML, Yakhini Z,
et al: Deregulation of cancer-related miRNAs is a common event in
both benign and malignant human breast tumors. Carcinogenesis.
35:76–85. 2014. View Article : Google Scholar
|
|
32
|
Liu C, Li M, Hu Y, Shi N, Yu H, Liu H and
Lian H: miR-486-5p attenuates tumor growth and lymphangiogenesis by
targeting neuropilin-2 in colorectal carcinoma. Onco Targets Ther.
9:2865–2871. 2016.PubMed/NCBI
|
|
33
|
Shi Y, Liang C, Li H, Shen W, Xiao Y, Chen
Q, Chen W and Ye Z: MicroRNA-486 suppressed proliferation,
migration and invasion of osteosarcoma cells via directly targeting
SIRT1. Int J Clin Exp Pathol. 9:9157–9165. 2016.
|
